-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية
المؤلفون: Mandanas, RA, Leibowitz, DS, Gharehbaghi, K, Tauchi, T, Burgess, GS, Miyazawa, K, Jayaram, HN, Boswell, HS
المصدر: Blood; September 1993, Vol. 82 Issue: 6 p1838-1847, 10p
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
المؤلفون: Mascarenhas J; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Kosiorek HE; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ., Prchal JT; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Rambaldi A; Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Berenzon D; Comprehensive Cancer Center, Wake Forest Baptist Health, Comprehensive Cancer Center, Winston-Salem, NC., Yacoub A; Kansas University Cancer Center, Leawood, KS., Harrison CN; Department of Haematology, Guy's Hospital, London, United Kingdom., McMullin MF; Queen's University Belfast, Belfast, United Kingdom., Vannucchi AM; University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Ewing J; Heart of England NHS Foundation Trust, UHB, Birmingham, United Kingdom., O'Connell CL; Keck School of Medicine, University of Southern California, Los Angeles, CA., Kiladjian JJ; Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, Paris, France., Mead AJ; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Winton EF; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Leibowitz DS; Oncology Department, Palo Alto Medical Foundation Sutter Health, Cupertino, CA., De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Arcasoy MO; Duke University School of Medicine, Durham, NC., Kessler CM; Georgetown University Medical Center, Washington, DC., Catchatourian R; Oncology Department, John H. Stroger Jr Hospital of Cook County, Chicago, IL., Rondelli D; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL., Silver RT; Richard T. Silver Myeloproliferative Neoplasms Center, New York Presbyterian Weill Cornell Medical Center, New York, NY., Bacigalupo A; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Nagler A; Hematology Department, Chaim Sheba Medical Center, Tel Hashomer, Israel., Kremyanskaya M; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Levine MF; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Arango Ossa JE; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., McGovern E; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Sandy L; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Salama ME; Mayo Clinic, Rochester, MN., Najfeld V; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Tripodi J; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Farnoud N; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Penson AV; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Weinberg RS; New York Blood Center, New York, NY., Price L; Department of Population Health and., Goldberg JD; Department of Population Health and.; Department of Environmental Medicine, New York University School of Medicine, New York, NY., Barbui T; Papa Giovanni XXIII Hospital, Foundation for Clinical Research (FROM), Bergamo, Italy., Marchioli R; Cardiovascular, Renal and Metabolic Medical and Scientific Services, IQVIA, Milan, Italy., Tognoni G; Department of Anaesthesia and Emergency Urgency, IRCCS, Ospedale Maggiore Policlinico, Milan, Italy., Rampal RK; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, Myeloproliferative Neoplasm Research Consortium (MPN-RC), New York, NY; and., Mesa RA; UT Health San Antonio Cancer Center, San Antonio, TX., Dueck AC; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ., Hoffman R; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
المصدر: Blood [Blood] 2022 May 12; Vol. 139 (19), pp. 2931-2941.
نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
مواضيع طبية MeSH: Polycythemia Vera*/drug therapy , Polycythemia Vera*/genetics , Thrombocythemia, Essential*/drug therapy , Thrombocythemia, Essential*/genetics , Thrombosis*/chemically induced , Thrombosis*/prevention & control, Disease Progression ; Humans ; Hydroxyurea/adverse effects ; Interferon-alpha/adverse effects